Inventor · disambiguated record
Markus Follmann
Also filed as: FOLLMANN MARKUS
53 granted patents·23 pending applications·393 citations·filing 2008–2023
98Inventor score
Top patents by PatentIndex Score
76 records- 0197US8420656B2Substituted 5-fluoro-1H-pyrazolopyridines and their useFOLLMANN MARKUS·Filed 2011·Granted Apr 16, 2013·62 cites·7 claims
- 0296US9993476B2Substituted 5-flouro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Granted Jun 12, 2018·16 cites·13 claims
- 0396US8921377B2Substituted 5-fluoro-1H-pyrazolopyridines and their useBAYER IP GMBH·Filed 2013·Granted Dec 30, 2014·30 cites·12 claims
- 0495US11439642B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·66 claims
- 0595US9216978B2Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseasesFOLLMANN MARKUS·Filed 2011·Granted Dec 22, 2015·35 cites·10 claims
- 0694US9126998B2Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Sep 8, 2015·17 cites·15 claims
- 0794US9096592B2Bicyclic aza heterocycles, and use thereofFOLLMANN MARKUS·Filed 2011·Granted Aug 4, 2015·28 cites·6 claims
- 0893US9023849B2Substituted fused imidazoles and pyrazoles and use thereofBAYER IP GMBH·Filed 2013·Granted May 5, 2015·26 cites·7 claims
- 0993US8859569B2Substituted annellated pyrimidines and use thereofFOLLMANN MARKUS·Filed 2012·Granted Oct 14, 2014·25 cites·8 claims
- 1092US9309239B2Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereofFOLLMANN MARKUS·Filed 2011·Granted Apr 12, 2016·9 cites·8 claims
- 1192US9266885B2Substituted 5-fluoro-1H-pyrazolopyridines and their useBAYER IP GMBH·Filed 2014·Granted Feb 23, 2016·11 cites·12 claims
- 1291US9090609B2Benzyl-substituted carbamates and use thereofFOLLMANN MARKUS·Filed 2011·Granted Jul 28, 2015·18 cites·10 claims
- 1391US9090610B2Fluoroalkyl-substituted pyrazolopyridines and use thereofFOLLMANN MARKUS·Filed 2012·Granted Jul 28, 2015·16 cites·5 claims
- 1490US8778964B2Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Jul 15, 2014·15 cites·6 claims
- 1589US10736896B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2018·Granted Aug 11, 2020·2 cites·7 claims
- 1689US8981104B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2013·Granted Mar 17, 2015·13 cites·12 claims
- 1787US8946215B2Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Feb 3, 2015·10 cites·8 claims
- 1887US8765769B2Ring-fused 4-aminopyrimidines and use thereof as stimulators of soluable guanylate cyclasesFOLLMANN MARKUS·Filed 2011·Granted Jul 1, 2014·10 cites·6 claims
- 1986US12064429B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 2082US9688636B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2015·Granted Jun 27, 2017·3 cites·8 claims
- 2182US9266871B2Trifluoromethyl-substituted fused pyrimidines and their useBayer Pharma AG·Filed 2014·Granted Feb 23, 2016·5 cites·17 claims
- 2281US9133191B2Substituted triazine derivatives and use thereof as stimulators of soluble guanylate cyclaseBAYER IP GMBH·Filed 2013·Granted Sep 15, 2015·5 cites·7 claims
- 2380US11166932B2Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereofBayer Pharma AG·Filed 2016·Granted Nov 9, 2021·2 cites·16 claims
- 2480US9624214B2Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Apr 18, 2017·3 cites·14 claims
- 2579US10053428B25-aminotetrahydroquinoline-2-carboxylic acids and their useBayer Pharma AG·Filed 2017·Granted Aug 21, 2018·2 cites·34 claims
- 2678US9422285B2Substituted pyrazolo[1,5-A]-pyridine-3-carboxamides and use thereofBayer Pharma AG·Filed 2014·Granted Aug 23, 2016·4 cites·13 claims
- 2778US7897616B2Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipasesSANOFI AVENTIS·Filed 2008·Granted Mar 1, 2011·3 cites·9 claims
- 2877US9605008B2Benzyl-1H-pyrazolo[3,4-b]pyridines and use thereofBayer Pharma AG·Filed 2014·Granted Mar 28, 2017·3 cites·24 claims
- 2977US9150580B2Substituted imidazopyridines and the use thereofFOLLMANN MARKUS·Filed 2012·Granted Oct 6, 2015·3 cites·4 claims
- 3076US9776997B23-aryl-substituted imidazo[1,2-A]pyridines and their useBayer Pharma AG·Filed 2014·Granted Oct 3, 2017·3 cites·8 claims
- 3176US9498480B2Substituted azabicycles and use thereofBAYER IP GMBH·Filed 2013·Granted Nov 22, 2016·3 cites·6 claims
- 3274US11912692B2Substituted S-alaninate derivativesBAYER AG·Filed 2023·Granted Feb 27, 2024·0 cites·17 claims
- 3372US12427131B2Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination with an inhibitor of neutral endopeptidase (NEP inhibitor) and/or an angiotensin AII antagonist and the use thereofBayer Pharma AG·Filed 2021·Granted Sep 30, 2025·0 cites·8 claims
- 3472US10189856B2Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc)HIRTH DIETRICH CLAUDIA·Filed 2011·Granted Jan 29, 2019·4 cites·7 claims
- 3571US9505786B2Substituted annulated triazines and use thereofBAYER IP GMBH·Filed 2015·Granted Nov 29, 2016·1 cites·6 claims
- 3668US8378092B2Chlorothiophene-amides as inhibitors of coagulation factors Xa and thrombinSANOFI SA·Filed 2010·Granted Feb 19, 2013·2 cites·9 claims
- 3765US9688699B23-(pyrimidine-2-yl)imidazo[1,2-a]pyridinesBayer Pharma AG·Filed 2015·Granted Jun 27, 2017·1 cites·11 claims
- 3863US2025002483A1Substituted s-alaninate derivativesBAYER AG·Filed 2022·Application pending·0 cites
- 3960US2016129004A1Substituted 5-fluoro-1h-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Application pending·0 cites
- 4059US2015274719A1Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Application pending·0 cites
- 4158US2009149519A1Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicamentsSANOFI AVENTIS·Filed 2008·Application pending·0 cites
- 4257US10265314B2SGC stimulators in combination with additional treatment for the therapy of cystic fibrosisBayer Pharma AG·Filed 2014·Granted Apr 23, 2019·0 cites·8 claims
- 4356US10052312B2Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2017·Granted Aug 21, 2018·0 cites·2 claims
- 4454US2015105374A1Substituted annellated pyrimidines and use thereofBAYER IP GMBH·Filed 2014·Application pending·0 cites
- 4552US9550788B2Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereofSANOFI SA·Filed 2014·Granted Jan 24, 2017·0 cites·14 claims
- 4652US8822449B2Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereofRACKELMANN NILS·Filed 2009·Granted Sep 2, 2014·0 cites·15 claims
- 4752US8748465B2Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicamentsSANOFI SA·Filed 2013·Granted Jun 10, 2014·0 cites·12 claims
- 4851US8389764B2Urea and sulfamide derivatives as inhibitors of TAFIaKALLUS CHRISTOPHER·Filed 2009·Granted Mar 5, 2013·0 cites·7 claims
- 4951US8263621B2Tartrate derivatives for use as coagulation factor IXa inhibitorsSTEINHAGEN HENNING·Filed 2009·Granted Sep 11, 2012·0 cites·3 claims
- 5050US8097758B2Isoserine derivatives for use as coagulation factor IXa inhibitorsSTEINHAGEN HENNING·Filed 2009·Granted Jan 17, 2012·0 cites·8 claims
Showing the top 50 of 76 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Markus Follmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →